Abnormal cognitive test results | Statistic | p value | Significant post-hoc differences | |||
---|---|---|---|---|---|---|
0 | 1 | 2 | ||||
n = 55 | n = 68 | n = 77 | ||||
Ischemic heart disease | 43% | 34% | 27% | χ2(2, N = 200) = 3.05 | 0.22 | - |
Arrhythmia | 39% | 37% | 30% | χ2(2, N = 200) = 1.45 | 0.49 | - |
Heart failure | 24% | 30% | 29% | χ2(2, N = 200) = 0.81 | 0.67 | - |
Hypertension | 47% | 52% | 47% | χ2(2, N = 200) = 0.37 | 0.83 | - |
COPD | 26% | 19% | 16% | χ2(2, N = 200) = 2.00 | 0.37 | - |
Gastrointestinal disease | 22% | 18% | 13% | χ2(2, N = 200) = 1.80 | 0.41 | - |
Stroke/TIA | 19% | 21% | 21% | χ2(2, N = 200) = 0.16 | 0.92 | - |
Diabetes | 22% | 29% | 18% | χ2(2, N = 200) = 2.63 | 0.27 | - |
Cancer, nonskin | 31% | 30% | 25% | χ2(2, N = 200) = 0.72 | 0.70 | - |
Neurocognitive disorder | 6% | 4% | 12% | χ2(2, N = 200) = 3.21 | 0.22 | - |
Drugs in chart, mean(SD) | 7.1(3.8) | 7.6(4.0) | 6.6(3.7) | F(2, 197) = 1.20 | 0.30 | - |
Charlson comorbidity index, mean(SD) | 2.3(1.7) | 2.4(1.4) | 2.1(1.5) | F(2, 197) = 0.77 | 0.47 | - |